Neurociencia cognitiva
Instituto de Salud Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (41)
2023
-
A 3-Year Retrospective Study of the Impact of Integrating an Addiction Liaison Team into an Outpatient Alcoholism Treatment Programme
Alcohol and Alcoholism, Vol. 58, Núm. 5, pp. 515-522
2022
-
Brain oscillatory functioning after long-term alcohol abstinence
International Journal of Psychophysiology, Vol. 177, pp. 240-248
-
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
International Journal of Molecular Sciences, Vol. 23, Núm. 9
-
Neuropsychological Symptom Identification and Classification in the Hospitalized COVID-19 Patients During the First Wave of the Pandemic in a Front-Line Spanish Tertiary Hospital
Frontiers in Psychiatry, Vol. 13
-
Sex Differences in Plasma Lysophosphatidic Acid Species in Patients with Alcohol and Cocaine Use Disorders
Brain Sciences, Vol. 12, Núm. 5
-
Spanish Consortium for Ageing Normative Data (SCAND): Semantic Verbal Fluency Tests
Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, Vol. 37, Núm. 2, pp. 352-364
-
Understanding the basis of major depressive disorder in oncological patients: Biological links, clinical management, challenges, and lifestyle medicine
Frontiers in Oncology, Vol. 12
2021
-
COVID-19-Related Neuropsychiatric Symptoms in Patients With Alcohol Abuse Conditions During the SARS-CoV-2 Pandemic: A Retrospective Cohort Study Using Real World Data From Electronic Health Records of a Tertiary Hospital
Frontiers in Neurology, Vol. 12
-
Foveal Avascular zone and Choroidal thickness are decreased in subjects with hard Drusen and without high genetic risk of developing Alzheimer’s disease
Biomedicines, Vol. 9, Núm. 6
-
MADRID+90 study on factors associated with longevity: Study design and preliminary data
PLoS ONE, Vol. 16, Núm. 5 May
-
Metabolomic connections between schizophrenia, antipsychotic drugs and metabolic syndrome: A variety of players
Current Pharmaceutical Design, Vol. 27, Núm. 39, pp. 4049-4061
-
Plasma concentrations of lysophosphatidic acid and autotaxin in abstinent patients with alcohol use disorder and comorbid liver disease
Biomedicines, Vol. 9, Núm. 9
2020
-
Abstinent patients with alcohol use disorders show an altered plasma cytokine profile: Identification of both interleukin 6 and interleukin 17A as potential biomarkers of consumption and comorbid liver and pancreatic diseases
Journal of Psychopharmacology, Vol. 34, Núm. 11, pp. 1250-1260
-
Effects of including mutual aid groups in the adherence of a continuing care programme of alcohol dependent patients carried out in a Primary Care setting
Atencion Primaria, Vol. 52, Núm. 8, pp. 555-562
-
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Frontiers in Psychiatry, Vol. 11
-
Ocular vascular changes in mild alzheimer’s disease patients: Foveal avascular zone, choroidal thickness, and onh hemoglobin analysis
Journal of Personalized Medicine, Vol. 10, Núm. 4, pp. 1-13
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Psychophysiological Correlates of Emotional- And Alcohol-Related Cues Processing in Offspring of Alcohol-Dependent Patients
Alcohol and Alcoholism, Vol. 55, Núm. 4, pp. 374-381
-
Stop! – The automatic tendency of action, inhibition and frontal activation in individuals with alcohol-use disorder in abstinence
International Journal of Psychophysiology, Vol. 158, pp. 123-135
-
The Role of Chronic Stress as a Trigger for the Alzheimer Disease Continuum
Frontiers in Aging Neuroscience, Vol. 12